XML 13 R14.htm IDEA: XBRL DOCUMENT v3.20.1
Note 7 - Stock-based Compensation
3 Months Ended
Apr. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
Note
7
- Stock-based compensation 
 
The Company’s
2017
Omnibus Stock Incentive Plan dated
June 13, 2017,
as amended, which the Company's stockholders approved in
June 2017 (
"2017
Plan"), is the only incentive stock plan under which new equity incentive awards
may
be granted.
 
The Company has prior incentive plans under which previously granted awards remain outstanding, but under which
no
new awards
may
be granted. At
April 30, 2020
the Company had reserved a total of
641,623
shares for grants and issuances under these incentive stock plans, which includes a reserve for issuances pursuant to unvested or unexercised prior awards, and shares for new grants or issuances pursuant to the
2017
Plan.
 
While the
2017
Plan provides for the grant of deferred shares, non-qualified stock options, incentive stock options, restricted shares, restricted stock units, and performance-based restricted stock units intended to qualify under section
422
of the Internal Revenue Code, to date the Company has issued only restricted shares and restricted stock units under the
2017
Plan. The
2017
Plan authorizes awards to officers, employees, consultants and independent directors.
 
The Company has stock-based compensation awards that can be granted to eligible employees, officers or independent directors. The following were the Company's stock-based compensation expenses for the periods presented:
 
   
Three Months Ended April 30,
 
   
2020
   
2019
 
Stock-based compensation expense
  $
2
    $
4
 
Restricted stock-based compensation expense
   
217
     
150
 
Total stock-based compensation expense
  $
219
    $
154
 
 
Stock Options
 
The Company did
not
grant any stock options during the
three
months ended
April 30, 2020
. The following tables summarizes the Company's stock option activity:
 
Option activity
 
No. of Shares Underlying Options
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual Term
   
Aggregate Intrinsic Value
 
Outstanding at January 31, 2020
   
132
    $
8.98
     
3.2
    $
160
 
Exercised
   
-
     
-
     
 
     
-
 
Expired or forfeited
   
(4
)    
-
     
 
     
 
 
Outstanding at April 30, 2020
   
128
     
8.98
     
3.1
     
2
 
                                 
Exercisable at April 30, 2020
   
125
    $
9.01
     
3.0
    $
2
 
 
No
stock options were exercised during the 
three
months ended
April 30, 2020
 
Unvested option activity
 
No. of Shares Underlying Options
   
Weighted Average Grant Date Fair Value
   
Aggregate Intrinsic Value
 
Outstanding at January 31, 2020
   
3
    $
7.33
    $
4
 
Vested
   
-
     
 
     
 
 
Expired or forfeited
   
-
     
-
     
 
 
Outstanding at April 30, 2020
   
3
    $
7.33
    $
-
 
 
As of
April 30, 2020
, there was less than $
0.1
million of total unrecognized compensation expense related to unvested stock options. The expense is expected to be recognized over a weighted average period of 
0.1
years.
 
Restricted stock
 
The following table summarizes the Company's restricted stock activity for the 
three
months ended
April 30,
2020
:
 
Restricted stock activity
 
Restricted Shares
   
Weighted Average Grant Price Per Share
   
Aggregate Intrinsic Value
 
Outstanding at January 31, 2020
   
321
    $
8.89
    $
2,857
 
Granted
   
-
     
-
     
 
 
Vested and issued    
-
     
-
     
 
 
Forfeited or retired for taxes
   
(0
)    
9.79
     
 
 
Outstanding at April 30, 2020
   
321
    $
8.89
    $
2,856
 
 
A
s of
April 30, 2020
, there was
$1.3
million of unrecognized compensation expense related to unvested restricted stock granted under the plans. That cost is expected to be recognized over a weighted average period of
2.0
 years.